Search for: "HOFFMAN-LAROCHE LIMITED" Results 21 - 40 of 41
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Apr 2007, 1:14 am
Hook of Florida's Hook Bolton Mitchell Kirkland & McGhee, who has spent much of his career in defense work, has joined with four other firms in Florida and New Jersey to pursue the suits against Hoffman-LaRoche. [read post]
6 Nov 2008, 3:08 am
Hoffman-LaRoche Inc., 541 F.3d 1115, 1125 (Fed. [read post]
27 Feb 2014, 6:00 am
  Over the last year, we have posted on decisions on case consolidation, summary judgment, punitive damages, limiting Dr. [read post]
21 Feb 2014, 8:53 am
Not too long ago we were asked what we thought about warning claims involving medication guides. [read post]
14 Sep 2012, 4:20 am by Max Kennerly, Esq.
Hoffman-LaRoche, Pfizer, SmithKline, and all the pharmaceutical companies had done reproductive testing routinely since the 1940s. [read post]
2 Jun 2011, 12:46 pm by Bexis
Hoffmann-LaRoche, Inc., 540 So.2d 102, 104 (Fla. 1989). [read post]
15 May 2010, 2:22 pm
"'[T]he types of conduct which can form a basis for finding a case exceptional [include] . . . inequitable conduct before the P.T.O., [and] misconduct during litigation.'" Hoffman-LaRoche, Inc. v. [read post]
12 Oct 2011, 8:31 am by Lawrence B. Ebert
“Discretion is not whim, and limiting discretion according to legal standards helps promote the basic principle of justice that like cases should be decided alike. [read post]
11 May 2011, 5:28 pm by Michael O'Brien
Hoffman-LaRoche, Inc., which departed from all existing case law at that moment.[22]  In Molecular Diagnostics, the plaintiff, a direct purchaser of the subject patented product, brought suit under Section 1 of the Sherman Act charging that it had been forced to pay artificially inflated prices for the product as a result of defendants' enforcement of the patent, which plaintiffs allege was obtained by fraud on the PTO. [read post]
9 Jan 2014, 1:37 pm
Hoffman-La Roche, Inc., 2010 WL 3034453, at *22 (N.J. [read post]
24 May 2007, 10:40 am
Hoffman-LaRoche, Inc., 949 F.2d 806, 816 (5th Cir. 1992) (applying Mississippi law). [read post]
2 Jul 2009, 5:18 am
Hoffman-LaRoche, Inc., 949 F.2d 806, 814 (5th Cir. 1992) (no presumption in unavoidably unsafe products because the effect of a presumption on an inherent risk would be to presume that nobody would ever use the product); Lineberger v. [read post]
19 Nov 2009, 10:51 am by Beck/Herrmann
Hoffman LaRoche, Inc., 917 A.2d 767 (N.J. 2007) (which we reviewed here), the court held that in personal injury actions, the individual plaintiff's home state/place where the injury occurred should control: [H]aving considered the contacts relevant to the competing interests of the states in light of Rowe, this Court concludes that the competing interests of the states, the most important factor, weighs in favor of applying the law of each plaintiff's home jurisdiction. [read post]
7 Nov 2014, 5:52 am
Hoffman-LaRoche, Inc., 949 F.2d 806, 814 (5th Cir. 1992) (applying Mississippi law), which you can find later in this post.What happens when a heeding presumption is imposed concerning a risk warning? [read post]
27 May 2010, 3:40 pm by Bexis
”Before get to the cases, however, we’ll also supply links to some relevant FDA documents.(1) the FDA’s 1996 Annual Adverse Experience Drug Report, in which the agency states that AERs “may not be used to calculate incidences or estimates of drug risk”;(2) the FDA’s 2003 Pharmaceutical Safety Assessments Analysis, which characterized causation assessments based upon AERs as “dubious,” “inefficient,” and “low quality”;(3) the… [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’… [read post]
11 Jul 2008, 4:30 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]